DR. REDDYS LABORATORIES LTD.
NSE : DRREDDYBSE : 500124ISIN
CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse
: Dr. Reddy's
BSE3618.15-62.6 (-1.7 % )
PREV CLOSE (Rs.) 3680.75
OPEN PRICE (Rs.) 3724.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 68835
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE3621.55 -61.45 (-1.67 % )
PREV CLOSE(Rs.) 3683.00
OPEN PRICE (Rs.) 3740.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 3621.55 (889 )
VOLUME 1960953
TODAY'S LOW / HIGH(Rs.)
52 WK LOW / HIGH (Rs.)
Financial ratio
| Particulars | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 117.47 | 57.04 | 77.93 | 124.89 | 137.11 |
| CEPS(Rs) | 183.19 | 119.86 | 137.74 | 178.58 | 181.71 |
| DPS(Rs) | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 |
| Book NAV/Share(Rs) | 840.01 | 752.35 | 734.72 | 731.49 | 572.92 |
| Tax Rate(%) | 16.83 | 32.43 | 19.08 | 26.27 | 19.42 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 20.57 | 16.46 | 17.41 | 23.03 | 23.13 |
| EBIT Margin(%) | 15.41 | 10.01 | 11.39 | 18.89 | 19.91 |
| Pre Tax Margin(%) | 14.84 | 9.46 | 10.94 | 18.36 | 19.19 |
| PAT Margin (%) | 12.34 | 6.39 | 8.86 | 13.54 | 15.47 |
| Cash Profit Margin (%) | 19.69 | 13.93 | 16.09 | 19.57 | 20.50 |
| Performance Ratios | |||||
| ROA(%) | 8.66 | 4.23 | 6.14 | 11.05 | 13.67 |
| ROE(%) | 14.42 | 7.40 | 10.20 | 18.95 | 26.63 |
| ROCE(%) | 13.41 | 8.21 | 9.77 | 19.55 | 22.69 |
| Asset Turnover(x) | 0.70 | 0.66 | 0.69 | 0.82 | 0.88 |
| Sales/Fixed Asset(x) | 0.87 | 0.86 | 0.92 | 1.13 | 1.23 |
| Working Capital/Sales(x) | 2.96 | 3.96 | 11.23 | 2.86 | 2.99 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.15 | 1.17 | 1.09 | 0.89 | 0.81 |
| Receivable days | 94.98 | 100.33 | 101.86 | 96.43 | 89.72 |
| Inventory Days | 74.03 | 73.63 | 69.56 | 60.11 | 60.27 |
| Payable days | 39.46 | 37.10 | 31.00 | 28.67 | 28.48 |
| Valuation Parameters | |||||
| PER(x) | 23.62 | 36.51 | 33.78 | 24.30 | 25.43 |
| PCE(x) | 15.14 | 17.37 | 19.11 | 16.99 | 19.19 |
| Price/Book(x) | 3.30 | 2.77 | 3.58 | 4.15 | 6.09 |
| Yield(%) | 0.72 | 0.96 | 0.76 | 0.66 | 0.57 |
| EV/Net Sales(x) | 3.22 | 2.76 | 3.39 | 3.51 | 4.12 |
| EV/Core EBITDA(x) | 14.13 | 15.71 | 18.22 | 14.08 | 16.42 |
| EV/EBIT(x) | 20.86 | 27.55 | 29.79 | 18.57 | 20.57 |
| EV/CE(x) | 2.25 | 1.79 | 2.28 | 2.76 | 3.37 |
| M Cap / Sales | 2.98 | 2.42 | 3.07 | 3.33 | 3.96 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 8.17 | 0.60 | -8.81 | 3.63 | 11.99 |
| Core EBITDA Growth(%) | 40.27 | -5.19 | -31.87 | 2.99 | 10.15 |
| EBIT Growth(%) | 66.59 | -11.62 | -45.02 | -2.21 | 8.47 |
| PAT Growth(%) | 108.92 | -27.43 | -40.35 | -9.79 | 19.01 |
| EPS Growth(%) | 105.96 | -26.81 | -37.60 | -8.92 | 18.87 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.28 | 0.41 | 0.40 | 0.27 | 0.44 |
| Current Ratio(x) | 1.88 | 1.52 | 1.15 | 1.86 | 1.74 |
| Quick Ratio(x) | 1.31 | 1.10 | 0.81 | 1.46 | 1.36 |
| Interest Cover(x) | 26.78 | 18.14 | 25.51 | 35.61 | 27.80 |
| Total Debt/Mcap(x) | 0.08 | 0.15 | 0.11 | 0.06 | 0.07 |
